Class information for:
Level 1: TUMOR ASSOCIATED MACROPHAGES//TUMOR ASSOCIATED MACROPHAGE//TUMOUR ASSOCIATED MACROPHAGES

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
5519 1546 50.5 92%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
558 13805 CHEMOKINE//CXCR4//CHEMOKINES

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 TUMOR ASSOCIATED MACROPHAGES Author keyword 70 42% 8% 128
2 TUMOR ASSOCIATED MACROPHAGE Author keyword 31 48% 3% 47
3 TUMOUR ASSOCIATED MACROPHAGES Author keyword 27 63% 2% 27
4 TUMOR ASSOCIATED MACROPHAGES TAMS Author keyword 10 58% 1% 11
5 TUMOUR ASSOCIATED MACROPHAGE Author keyword 6 58% 0% 7
6 TUMOR ASSOCIATED MACROPHAGES TAM Author keyword 5 54% 0% 7
7 CD163 Author keyword 5 15% 2% 32
8 M2 MACROPHAGES Author keyword 5 26% 1% 15
9 CD68 Author keyword 5 12% 2% 36
10 CD204 Author keyword 4 39% 1% 9

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 TUMOR ASSOCIATED MACROPHAGES 70 42% 8% 128 Search TUMOR+ASSOCIATED+MACROPHAGES Search TUMOR+ASSOCIATED+MACROPHAGES
2 TUMOR ASSOCIATED MACROPHAGE 31 48% 3% 47 Search TUMOR+ASSOCIATED+MACROPHAGE Search TUMOR+ASSOCIATED+MACROPHAGE
3 TUMOUR ASSOCIATED MACROPHAGES 27 63% 2% 27 Search TUMOUR+ASSOCIATED+MACROPHAGES Search TUMOUR+ASSOCIATED+MACROPHAGES
4 TUMOR ASSOCIATED MACROPHAGES TAMS 10 58% 1% 11 Search TUMOR+ASSOCIATED+MACROPHAGES+TAMS Search TUMOR+ASSOCIATED+MACROPHAGES+TAMS
5 TUMOUR ASSOCIATED MACROPHAGE 6 58% 0% 7 Search TUMOUR+ASSOCIATED+MACROPHAGE Search TUMOUR+ASSOCIATED+MACROPHAGE
6 TUMOR ASSOCIATED MACROPHAGES TAM 5 54% 0% 7 Search TUMOR+ASSOCIATED+MACROPHAGES+TAM Search TUMOR+ASSOCIATED+MACROPHAGES+TAM
7 CD163 5 15% 2% 32 Search CD163 Search CD163
8 M2 MACROPHAGES 5 26% 1% 15 Search M2+MACROPHAGES Search M2+MACROPHAGES
9 CD68 5 12% 2% 36 Search CD68 Search CD68
10 CD204 4 39% 1% 9 Search CD204 Search CD204

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 TUMOR ASSOCIATED MACROPHAGES 104 26% 23% 353
2 INFILTRATING MACROPHAGES 23 54% 2% 30
3 ALTERNATIVE ACTIVATION 19 15% 8% 123
4 ANTICANCER THERAPIES 16 48% 2% 25
5 INFILTRATING MYELOID CELLS 15 73% 1% 11
6 PROMOTE TUMOR 8 75% 0% 6
7 PARACRINE LOOP 8 32% 1% 21
8 TUMOR DERIVED CCL5 8 100% 0% 5
9 TNF A 7 67% 0% 6
10 TIE2 EXPRESSING MONOCYTES 6 24% 1% 21

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines 2014 120 44 45%
Macrophage Diversity Enhances Tumor Progression and Metastasis 2010 819 124 49%
Tumor-Associated Macrophages: From Mechanisms to Therapy 2014 78 122 39%
The interaction of anticancer therapies with tumor-associated macrophages 2015 5 97 41%
Macrophage Regulation of Tumor Responses to Anticancer Therapies 2013 115 78 64%
Macrophage biology in development, homeostasis and disease 2013 330 121 17%
Immune cell promotion of metastasis 2015 4 119 31%
Macrophage plasticity and polarization in tissue repair and remodelling 2013 194 136 25%
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm 2010 579 104 37%
Tumor-associated macrophages as an emerging target against tumors: Creating a new path from bench to bedside 2015 2 75 52%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 STUDY REPROD BIOL WOMENS HLTH 4 31% 0.8% 12
2 REPROD BIOL WOMENS HLTH 4 56% 0.3% 5
3 ANGIOGENESIS TUMOR TARGETING UNIT 3 33% 0.5% 8
4 INMUNOMETAB 2 67% 0.1% 2
5 ECCELLENZA INNOVAZ DIAGNOST TER EUT 2 28% 0.3% 5
6 MYELOID CELL IMMUNOL 1 15% 0.6% 9
7 BIOL THER IES 1 38% 0.2% 3
8 GEN ONCOL TRAUMA SURG 1 100% 0.1% 2
9 HUMAN INNATE IMMUN 1 100% 0.1% 2
10 IDET 1 23% 0.3% 5

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000149569 MYELOID DERIVED SUPPRESSOR CELLS//MDSC//MYELOID DERIVED SUPPRESSOR CELL
2 0.0000125633 MONOCYTE SUBSETS//MONOCYTE HETEROGENEITY//MONOCYTE SUBSET
3 0.0000083312 ERRMECEEA 1391//GENET MED OBSTET GYNECOL//SCIRRHOUS GASTRIC CARCINOMA
4 0.0000083199 MONOCYTE CHEMOATTRACTANT PROTEIN 1//MCP 1 POLYMORPHISM//REGULATED UPON ACTIVATION
5 0.0000079637 JEFFERSON STEM CELL BIOL REGENERAT MED//CANCER ASSOCIATED FIBROBLASTS//CANCER ASSOCIATED FIBROBLAST
6 0.0000079471 FOXP3//TUMOR INFILTRATING LYMPHOCYTES//INTEGRAT CANC IMMUNOL
7 0.0000075704 CSF 1//MACROPHAGE COLONY STIMULATING FACTOR//M CSF
8 0.0000073867 GLASGOW PROGNOSTIC SCORE//NEUTROPHIL TO LYMPHOCYTE RATIO//NEUTROPHIL LYMPHOCYTE RATIO
9 0.0000069315 UNITA OPERAT ASSISTENZIALE GINECOL ONCOL//CD1A//CDLA
10 0.0000065315 BB 10010//CK BETA 8//STEM CELL INHIBITOR